2.1. Analysis.
Comparison 2: Convalescent plasma versus standard plasma for individuals with moderate to severe disease, Outcome 1: All‐cause mortality at up to day 28
Comparison 2: Convalescent plasma versus standard plasma for individuals with moderate to severe disease, Outcome 1: All‐cause mortality at up to day 28